ITRACONAZOLE capsules are indicated for:
- persistent vulvovaginal candidiasis which does not respond to conventional therapy.
- Dermatomycosis which does not respond to conventional therapy.
- Although proof of efficacy is limited, ITRACONAZOLE capsules have been used in fungal keratitis.
- Onychomycosis, caused by dermatophytes and/or yeasts and which does not respond to other therapy.
- Although proof of efficacy is limited, ITRACONAZOLE capsules have been used in: systemic aspergillosis and candidiasis, histoplasmosis, sporotrichosis, para coccidioidomycosis and blastomycosis.